Moskot Julia

Clinical Operation Director
Hepatera
Maxwell Biotech Group
Russian Federation

Business Expert Biomedical Sciences
Biography

In 2007 graduated from I.M. Sechenov First Moscow State Medical University. Is engaged in research activities and medical analytics for more than 8 years. Has extensive experience in project management in the fields of commercial medicine, medical insurance, trade marketing and human resources. In 2014 joined «Maxwell Biotech Group» team and has been leading the projects of «Hepatera» and «Infectex» companies since then. Has experience applicable to regulatory support, study budget planning and management. Responsible for the Russian and international clinical trials organization (from initial stage to project closure), vendors selection, study documents analysis and preparation. 

Research Intrest

Myrcludex B, a peptide inhibiting the penetration of virus into the liver cells. Therapeutic focus: Chronic viral hepatitis B (HBV); chronic hepatitis D (HDV)